Search results
Results from the WOW.Com Content Network
In addition, certain features have been shown to increase the chances that depressed patients have a bipolar disorder, including atypical symptoms of depression like hypersomnia and hyperphagia, a family history of bipolar disorder, medication-induced hypomania, recurrent or psychotic depression, antidepressant refractory depression, and early ...
Bipolar I disorder, bipolar II disorder, others [5] Causes: Environmental and genetic [4] Risk factors: Family history, childhood abuse, long-term stress [4] Differential diagnosis: Attention deficit hyperactivity disorder, autism, personality disorders, schizophrenia, substance use disorder [4] Treatment: Psychotherapy, medications [4] Medication
Chronic effects of COVID-19 can lead to a prolonged inflammatory state, which can increase symptoms resembling an autoimmune disorder. [1] Many patients with COVID-19 experience psychological symptoms that can arise either from the direct actions of the virus, the chronic increase in inflammation or secondary effects, such as post-traumatic ...
On January 30, 2020, the COVID-19 pandemic is deemed a Public Health Emergency of International Concern by the World Health Organization (WHO). The public and healthcare professionals experience higher levels of anxiety as a result of increased worldwide knowledge. The WHO formally designates COVID-19 a pandemic on March 11, 2020.
Bipolar disorder is a mental disorder with cyclical periods of depression and periods of elevated mood. [1] The elevated mood is significant and is known as mania , a severe elevation that can be accompanied by psychosis in some cases, or hypomania , a milder form of mania.
Bipolar disorder, previously known as manic depression, is a mental disorder that causes periods of depression and periods of abnormally elevated mood. The altered mood is significant and is known as mania or hypomania , depending on its severity, or whether symptoms of psychosis are present.
A variety of other agents have been tried in bipolar disorder, including benzodiazepines, calcium channel blockers, L-methylfolate, and thyroid hormone. [2] Modafinil (Provigil) and pramipexole (Mirapex) have been suggested for treating cognitive dysfunction associated with bipolar depression, but evidence supporting their use is quite limited.
Longer-term effects of COVID-19 have become a prevalent aspect of the disease itself. These symptoms can be referred to by many names including post-COVID-19 syndrome, long COVID, and long haulers syndrome. An overall definition of post-COVID conditions (PCC) can be described as a range of symptoms that can last for weeks or months. [83]